Status:
UNKNOWN
Analgesic Efficacy of Magnesium Sulphate as an Adjuvant to Levobupivacaine in Erector Spinae Block for Acute Pain Management in Modified Radical Mastectomy
Lead Sponsor:
South Egypt Cancer Institute
Conditions:
Acute Pain
Eligibility:
FEMALE
25-70 years
Phase:
PHASE2
PHASE3
Brief Summary
To evaluate the analgesic efficacy of magnesium sulphate as adjuvants to levobupivacaine in erector spinae plane block in modified radical mastectomy surgery for acute pain management
Detailed Description
The participating female will be randomly allocated using computer generated randomization program (http://www.randoiler.org) into one of 2 groups. Group (C) / (I):20 patients (control group): Patie...
Eligibility Criteria
Inclusion
- female patient
- American society of anesthesiologists (ASA) I and II physical status
- age from 25 to 70 years old
- scheduled for either left or right modified radical mastectomy (MRM)
Exclusion
- infection of the skin at or near site of needle puncture
- coagulopathy,
- drug hypersensitivity or allergy to the studied drugs,
- central or peripheral neuropathy,
- significant organ dysfunction cardiac dysrrhythmias,
- obesity (BMI\>35kg/m2)
- recently use analgesic drugs
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04732390
Start Date
December 1 2019
End Date
July 1 2021
Last Update
February 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Egypt Cancer Institute
Asyut, Egypt, 171516